Literature DB >> 31517469

Release notice - Canadian Cancer Statistics 2019.

.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31517469      PMCID: PMC6756131          DOI: 10.24095/hpcdp.39.8/9.04

Source DB:  PubMed          Journal:  Health Promot Chronic Dis Prev Can        ISSN: 2368-738X            Impact factor:   3.240


× No keyword cloud information.
  11 in total

1.  Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of Oncology.

Authors:  Arielle Elkrief; Petr Kavan; Thierry Alcindor; Genevieve Redstone; Luca Petruccelli; Alla'a Ali; Doneal Thomas; Myriam Fernandez; Caroline Rousseau; Olga Aleynikova; Dawn Anderson; Gabriela Ghitulescu; Carol-Ann Vasilevsky; Richard Dalfen; Adrian Langleben; Sender Liberman
Journal:  BMJ Open Qual       Date:  2021-03

2.  Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer.

Authors:  Mei Li Pei; Zong Xia Zhao; Ting Shuang
Journal:  J Ovarian Res       Date:  2020-12-10       Impact factor: 4.234

3.  Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival.

Authors:  Julia D Labadie; Sevtap Savas; Tabitha A Harrison; Barb Banbury; Yuhan Huang; Daniel D Buchanan; Peter T Campbell; Steven J Gallinger; Graham G Giles; Marc J Gunter; Michael Hoffmeister; Li Hsu; Mark A Jenkins; Yi Lin; Shuji Ogino; Amanda I Phipps; Martha L Slattery; Robert S Steinfelder; Wei Sun; Bethany Van Guelpen; Xinwei Hua; Jane C Figuieredo; Rish K Pai; Rami Nassir; Lihong Qi; Andrew T Chan; Ulrike Peters; Polly A Newcomb
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.996

4.  Prognosticating Outcome in Pancreatic Head Cancer With the use of a Machine Learning Algorithm.

Authors:  Zarrukh Baig; Nawaf Abu-Omar; Rayyan Khan; Carlos Verdiales; Ryan Frehlick; John Shaw; Fang-Xiang Wu; Yigang Luo
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

5.  Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes.

Authors:  Meshach Asare-Werehene; Hideaki Tsuyoshi; Huilin Zhang; Reza Salehi; Chia-Yu Chang; Euridice Carmona; Clifford L Librach; Anne-Marie Mes-Masson; Chia-Ching Chang; Dylan Burger; Yoshio Yoshida; Benjamin K Tsang
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

6.  Canadian Expert Opinion on Breast Reconstruction Access: Strategies to Optimize Care during COVID-19.

Authors:  Kathryn V Isaac; Edward W Buchel; Muriel M Brackstone; Christopher Doherty; Joan E Lipa; Toni Zhong; John L Semple; Mitchell H Brown; Laura Snell; Mary-Helen Mahoney; Joshua Vorstenbosch; Margaret Wheelock; Sheina A Macadam; Christopher J Coroneos; Marie-Pascale Tremblay-Champagne; Sophocles H Voineskos; Jing Zhang; Ron Somogyi; Claire Temple-Oberle; Douglas Ross
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-02-28

7.  Long noncoding RNA LINC00857 promotes pancreatic cancer proliferation and metastasis by regulating the miR-130b/RHOA axis.

Authors:  Peng Chen; Zhirui Zeng; Jie Wang; Wenpeng Cao; Chunzhuo Song; Shan Lei; Yichuan Li; Zhangxia Ren
Journal:  Cell Death Discov       Date:  2022-04-13

8.  The Economic Burden of Cancer in Canada from a Societal Perspective.

Authors:  Roxanne Garaszczuk; Jean H E Yong; Zhuolu Sun; Claire de Oliveira
Journal:  Curr Oncol       Date:  2022-04-14       Impact factor: 3.109

9.  The Synergistic Antitumor Effect of 5-Fluorouracil Combined with Allicin against Lung and Colorectal Carcinoma Cells.

Authors:  Adrian Bogdan Țigu; Vlad-Alexandru Toma; Augustin Cătălin Moț; Ancuța Jurj; Cristian Silviu Moldovan; Eva Fischer-Fodor; Ioana Berindan-Neagoe; Marcel Pârvu
Journal:  Molecules       Date:  2020-04-22       Impact factor: 4.411

10.  Effect of berbamine on invasion and metastasis of human liver cancer SMMC-7721 cells and its possible mechanism.

Authors:  Bin-Bin Yu; Li-Li Liu; Jia-Dong Yan; Jian-Bo Cao; Ying Cao
Journal:  Anticancer Drugs       Date:  2022-01-01       Impact factor: 2.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.